Monthly Archives: August 2012

Skingenix, Inc. announces treatment of the first patient with the investigational product in patients with Diabetic Foot Ulcers in USA.

On 9 October 2012, in a Phase II randomized and controlled multicenter clinical trial, the first subject was successfully treated with Skingenix’s investigational product in USA. This clinical study is currently ongoing, in which a total of 35 patients with Diabetic Foot Ulcers will be treated with┬áthe investigational product. The study is currently recruiting eligible patients with Diabetic Foot Ulcers and is expected to be completed in 2013. For further details, please visit clinicaltrials.gov website.